ENTRY C00918 Compound NAME Chloramphenicol FORMULA C11H12Cl2N2O5 EXACT_MASS 322.0123 MOL_WEIGHT 323.13 REMARK Same as: D00104 REACTION R03065 R12674 ENZYME 1.14.99.67 2.3.1.28 BRITE Compounds with biological roles [BR:br08001] Antibiotics Others Aromatic compounds C00918 Chloramphenicol Prodrugs [br08324.html] C00918 Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00104)] D DERMATOLOGICALS D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE D06A ANTIBIOTICS FOR TOPICAL USE D06AX Other antibiotics for topical use D06AX02 Chloramphenicol D00104 Chloramphenicol (JP18/USP/INN) <JP> D10 ANTI-ACNE PREPARATIONS D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE D10AF Antiinfectives for treatment of acne D10AF03 Chloramphenicol D00104 Chloramphenicol (JP18/USP/INN) <JP> G GENITO URINARY SYSTEM AND SEX HORMONES G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS G01AA Antibiotics G01AA05 Chloramphenicol D00104 Chloramphenicol (JP18/USP/INN) <JP> J ANTIINFECTIVES FOR SYSTEMIC USE J01 ANTIBACTERIALS FOR SYSTEMIC USE J01B AMPHENICOLS J01BA Amphenicols J01BA01 Chloramphenicol D00104 Chloramphenicol (JP18/USP/INN) <JP> S SENSORY ORGANS S01 OPHTHALMOLOGICALS S01A ANTIINFECTIVES S01AA Antibiotics S01AA01 Chloramphenicol D00104 Chloramphenicol (JP18/USP/INN) <JP> S02 OTOLOGICALS S02A ANTIINFECTIVES S02AA Antiinfectives S02AA01 Chloramphenicol D00104 Chloramphenicol (JP18/USP/INN) <JP> S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS S03A ANTIINFECTIVES S03AA Antiinfectives S03AA08 Chloramphenicol D00104 Chloramphenicol (JP18/USP/INN) <JP> USP drug classification [BR:br08302(D00104)] Antibacterials Antibacterials, Other Chloramphenicol D00104 Chloramphenicol (JP18/USP/INN) Therapeutic category of drugs in Japan [BR:br08301(D00104)] 1 Agents affecting nervous system and sensory organs 13 Agents affecting sensory organs 131 Ophthalmic agents 1317 Ophthalmic antibiotics D00104 Chloramphenicol (JP18/USP/INN) 132 Otic and nasal agents 1325 Otolaryngologic antibiotics D00104 Chloramphenicol (JP18/USP/INN) 2 Agents affecting individual organs 25 Urogenital and anal organ agents 252 Genital organ agents 2521 Antibiotics D00104 Chloramphenicol (JP18/USP/INN) 26 Epidermides 263 Suppurative dermatosis agents 2634 Antibiotics for external use D00104 Chloramphenicol (JP18/USP/INN) 6 Agents against pathologic organisms and parasites 61 Antibiotics 615 Acting mainly on gram-positive bacteria, gram-negative bacteria, rickettsia and chlamydia 6151 Chloramphenicols D00104 Chloramphenicol (JP18/USP/INN) Classification of Japanese OTC drugs [BR:br08313(D00104)] Agents for integumentary system 56 Purulent skin remedies D00104 Chloramphenicol (JP18/USP/INN) Risk category of Japanese OTC drugs [BR:br08312(D00104)] Second-class OTC drugs Inorganic and organic chemicals Chloramphenicol D00104 Chloramphenicol (JP18/USP/INN) Drug groups [BR:br08330(D00104)] Antibacterial DG01576 Amphenicol type antibacterial DG00399 Chloramphenicol D00104 Chloramphenicol Metabolizing enzyme inhibitor DG01933 CYP2C19 inhibitor D00104 Chloramphenicol Antimicrobials [BR:br08307(D00104)] Antibacterials Protein biosynthesis inhibitor Amphenicol D00104 Chloramphenicol (JP18/USP/INN) <JP> Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00104)] Chemicals D00104 Chloramphenicol Drug metabolizing enzymes and transporters [br08309.html(D00104)] Drug metabolizing enzymes D00104 Prodrugs [br08324.html(D00104)] D00104 DBLINKS CAS: 56-75-7 PubChem: 4172 ChEBI: 17698 PDB-CCD: CLM NIKKAJI: J2.802I ATOM 20 1 C8y C 21.4912 -17.2957 2 C1c C 21.4912 -18.6950 3 C8x C 20.2843 -16.5833 4 C8x C 22.7171 -16.5833 5 C1c C 22.6980 -19.3947 6 O1a O 20.2780 -19.3884 7 C8x C 20.2843 -15.1710 8 C8x C 22.7171 -15.1710 9 N1b N 23.9048 -18.7015 10 C1b C 22.6915 -20.7940 11 C8y C 21.4912 -14.4777 12 C5a C 25.1114 -19.4012 13 O1a O 21.4783 -21.4872 14 N2b N 21.4912 -13.0784 #+ 15 C1c C 26.3247 -18.7078 16 O5a O 25.1114 -20.8005 17 O3a O 20.2843 -12.3787 18 O3a O 22.6915 -12.3659 #- 19 X Cl 27.5314 -19.4076 20 X Cl 26.3311 -17.3085 BOND 20 1 1 2 1 2 1 3 2 3 1 4 1 4 2 5 1 5 2 6 1 #Down 6 3 7 1 7 4 8 2 8 5 9 1 9 5 10 1 10 7 11 2 11 9 12 1 12 10 13 1 13 11 14 1 14 12 15 1 15 12 16 2 16 14 17 2 17 14 18 1 18 15 19 1 19 15 20 1 20 8 11 1 /// ENTRY C00919 Compound NAME Choline sulfate FORMULA C5H13NO4S EXACT_MASS 183.0565 MOL_WEIGHT 183.23 REACTION R01027 R01028 PATHWAY map02010 ABC transporters ENZYME 2.8.2.6 3.1.6.6 DBLINKS CAS: 4858-96-2 PubChem: 4173 ChEBI: 16822 KNApSAcK: C00001530 NIKKAJI: J814.134G ATOM 11 1 C1b C 22.9407 -16.8746 2 N1d N 24.2912 -16.8746 #+ 3 C1b C 22.2655 -15.7045 4 C1a C 25.2524 -18.4003 5 C1a C 25.1824 -15.3545 6 C1a C 26.0432 -16.8978 7 O2a O 20.9093 -15.7045 8 S4a S 19.5529 -15.7103 9 O1d O 19.5413 -14.2841 10 O1d O 18.2084 -15.7045 11 O1d O 19.5529 -17.0607 #- BOND 10 1 1 2 1 2 1 3 1 3 2 4 1 4 2 5 1 5 2 6 1 6 3 7 1 7 7 8 1 8 8 9 2 9 8 10 2 10 8 11 1 /// ENTRY C10632 Compound NAME Acronycine; Acronine FORMULA C20H19NO3 EXACT_MASS 321.1365 MOL_WEIGHT 321.37 REMARK Same as: D02378 REACTION R08471 PATHWAY map00996 Biosynthesis of various alkaloids map01063 Biosynthesis of alkaloids derived from shikimate pathway map01110 Biosynthesis of secondary metabolites BRITE Phytochemical compounds [BR:br08003] Alkaloids Alkaloids derived from tryptophan and anthranilic acid Acridone alkaloids C10632 Acronycine Secondary metabolites in pathway maps [br08011.html] Biosynthetic pathways and modules of secondary metabolites C10632 DBLINKS CAS: 7008-42-6 PubChem: 12815 ChEBI: 2437 KNApSAcK: C00002130 NIKKAJI: J8.881A ATOM 24 1 C8x C 19.7397 -14.6328 2 C8x C 19.7397 -16.0362 3 C8x C 20.9587 -16.7342 4 C8x C 20.9587 -13.9277 5 C8y C 22.1708 -14.6328 6 C8y C 22.1648 -16.0362 7 N4y N 23.3779 -16.7393 8 C8y C 23.3899 -13.9330 9 C8y C 24.6033 -14.6432 10 C8y C 24.5905 -16.0428 11 C8x C 27.0452 -14.6650 12 C8y C 25.8224 -13.9507 13 C8y C 27.0096 -16.0645 14 C8y C 25.7987 -16.7488 15 C2x C 25.8326 -18.1466 16 C2x C 26.9835 -18.8601 17 C1z C 28.2013 -18.1690 18 O2x O 28.2146 -16.7710 19 O5x O 23.3782 -12.5780 20 C1a C 23.3639 -18.1911 21 O2a O 25.8179 -12.6065 22 C1a C 29.4609 -18.8847 23 C1a C 29.4609 -17.4746 24 C1a C 27.0075 -11.9147 BOND 27 1 10 14 1 2 13 11 1 3 11 12 2 4 12 9 1 5 2 3 2 6 3 6 1 7 5 6 2 8 6 7 1 9 7 10 1 10 9 8 1 11 13 14 2 12 14 15 1 13 15 16 2 14 16 17 1 15 17 18 1 16 18 13 1 17 8 5 1 18 8 19 2 19 5 4 1 20 7 20 1 21 4 1 2 22 12 21 1 23 1 2 1 24 17 22 1 25 9 10 2 26 17 23 1 27 21 24 1 /// ENTRY C00440 Compound NAME 5-Methyltetrahydrofolate FORMULA C20H25N7O6 EXACT_MASS 459.1866 MOL_WEIGHT 459.46 REACTION R00946 R01217 R01224 R02289 R02573 R02912 R07168 R09270 R09271 R10136 R10243 R10333 PATHWAY map00670 One carbon pool by folate map00720 Other carbon fixation pathways map01100 Metabolic pathways map01120 Microbial metabolism in diverse environments map01200 Carbon metabolism map01523 Antifolate resistance map04980 Cobalamin transport and metabolism map04981 Folate transport and metabolism MODULE M00377 Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) NETWORK nt06030 Methionine metabolism nt06038 Folate metabolism ENZYME 1.5.1.20 1.5.1.53 1.5.1.54 1.5.7.1 2.1.1.13 2.1.1.19 2.1.1.258 2.1.1.269 2.1.1.341 2.1.1.378 2.1.1.385 2.1.1.389 2.1.1.- 2.3.1.169 DBLINKS CAS: 134-35-0 PubChem: 3729 ChEBI: 15641 KNApSAcK: C00007252 PDB-CCD: C2F THH NIKKAJI: J356.349I ATOM 33 1 N4x N 9.5340 -17.5883 2 C8y C 9.5340 -18.9898 3 N5x N 10.7254 -19.6907 4 C8y C 11.9868 -18.9898 5 C8y C 11.9868 -17.5883 6 C8y C 10.7254 -16.8875 7 N1x N 13.1782 -19.6907 8 C1x C 14.3695 -18.9898 9 C1y C 14.3695 -17.5883 10 N1y N 13.1782 -16.8875 11 O5x O 10.7254 -15.4859 12 N1a N 8.3174 -19.6858 13 C1b C 15.5834 -16.8875 14 N1b N 16.7972 -17.5883 15 C8y C 18.0110 -16.8875 16 C8x C 19.2269 -17.5895 17 C8x C 20.4407 -16.8887 18 C8y C 20.4407 -15.4871 19 C8x C 19.2248 -14.7851 20 C8x C 18.0110 -15.4859 21 C5a C 21.6803 -14.7851 22 N1b N 22.8941 -15.4859 23 O5a O 21.6862 -13.3839 24 C1c C 24.1267 -14.7741 25 C1b C 25.3332 -15.4706 26 C1b C 26.5169 -14.7870 27 C6a C 27.7122 -15.4771 28 O6a O 28.9015 -14.7903 29 O6a O 27.7124 -16.8872 30 C6a C 24.1264 -13.3837 31 O6a O 22.9006 -12.6762 32 O6a O 25.3282 -12.6893 33 C1a C 13.1787 -15.4618 BOND 35 1 1 2 1 2 2 3 2 3 3 4 1 4 4 5 2 5 5 6 1 6 1 6 1 7 4 7 1 8 7 8 1 9 8 9 1 10 9 10 1 11 5 10 1 12 6 11 2 13 2 12 1 14 9 13 1 #Up 15 13 14 1 16 14 15 1 17 15 16 2 18 16 17 1 19 17 18 2 20 18 19 1 21 19 20 2 22 15 20 1 23 18 21 1 24 21 22 1 25 21 23 2 26 22 24 1 27 24 25 1 28 25 26 1 29 26 27 1 30 27 28 1 31 27 29 2 32 24 30 1 #Down 33 30 31 2 34 30 32 1 35 10 33 1 /// ENTRY C00441 Compound NAME L-Aspartate 4-semialdehyde; Aspartate beta-semialdehyde; L-Aspartic 4-semialdehyde FORMULA C4H7NO3 EXACT_MASS 117.0426 MOL_WEIGHT 117.10 REACTION R01773 R01775 R02291 R02293 R06977 R08568 R08650 R09079 R09080 R09805 R10147 R10673 R12505 R13291 PATHWAY map00260 Glycine, serine and threonine metabolism map00261 Monobactam biosynthesis map00270 Cysteine and methionine metabolism map00300 Lysine biosynthesis map00330 Arginine and proline metabolism map00400 Phenylalanine, tyrosine and tryptophan biosynthesis map00997 Biosynthesis of various other secondary metabolites map00998 Biosynthesis of various antibiotics map01100 Metabolic pathways map01110 Biosynthesis of secondary metabolites map01120 Microbial metabolism in diverse environments map01210 2-Oxocarboxylic acid metabolism map01230 Biosynthesis of amino acids MODULE M00016 Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine M00017 Methionine biosynthesis, aspartate => homoserine => methionine M00018 Threonine biosynthesis, aspartate => homoserine => threonine M00033 Ectoine biosynthesis, aspartate => ectoine M00525 Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine M00526 Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine M00527 Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine M00905 Grixazone biosynthesis, aspartate 4-semialdehyde => grixazone B M00919 Ectoine degradation, ectoine => aspartate ENZYME 1.1.1.3 1.2.1.11 1.2.1.- 1.5.1.43 1.5.1.55 2.2.1.10 2.6.1.46 2.6.1.76 2.8.1.16 4.1.2.56 4.3.3.7 DBLINKS PubChem: 3730 ChEBI: 13086 18051 KNApSAcK: C00007469 NIKKAJI: J457.019G ATOM 8 1 O6a O 15.6108 -16.5208 2 C6a C 16.8232 -15.8207 3 C1c C 18.0358 -16.5208 4 C1b C 19.2483 -15.8207 5 C4a C 20.4607 -16.5208 6 O4a O 21.6733 -15.8207 7 O6a O 16.8232 -14.4209 8 N1a N 18.0358 -17.9206 BOND 7 1 1 2 1 2 2 3 1 3 3 4 1 4 4 5 1 5 5 6 2 6 2 7 2 7 3 8 1 #Down /// ENTRY C00911 Compound NAME Ribonucleoside FORMULA C5H9O4R COMMENT Generic compound in reaction hierarchy REACTION R03060 R07297 ENZYME 3.1.3.5 3.1.3.6 DBLINKS PubChem: 4166 ChEBI: 18254 ATOM 10 1 C1y C 26.7002 -18.2412 2 C1y C 27.1138 -19.5463 3 O2x O 27.8013 -17.4489 4 C1b C 25.4069 -17.8102 5 C1y C 28.4887 -19.5463 6 O1a O 26.3099 -20.6474 7 C1y C 28.9083 -18.2412 8 O1a O 25.1273 -16.4819 9 O1a O 29.2928 -20.6474 10 R R 29.9569 -16.8779 BOND 10 1 1 2 1 2 1 3 1 3 1 4 1 #Up 4 2 5 1 5 2 6 1 #Down 6 3 7 1 7 4 8 1 8 5 9 1 #Down 9 7 10 1 #Up 10 5 7 1 /// ENTRY C00916 Compound NAME Cephalosporin C FORMULA C16H21N3O8S EXACT_MASS 415.1049 MOL_WEIGHT 415.42 REACTION R03062 R03063 R03064 R07400 PATHWAY map00311 Penicillin and cephalosporin biosynthesis map01100 Metabolic pathways map01110 Biosynthesis of secondary metabolites map07012 Cephalosporins - parenteral agents map07013 Cephalosporins - oral agents ENZYME 1.4.3.3 2.3.1.175 2.6.1.74 3.1.1.41 BRITE Compounds with biological roles [BR:br08001] Antibiotics beta-Lactams Cephems C00916 Cephalosporin C DBLINKS CAS: 61-24-5 PubChem: 4170 ChEBI: 15776 PDB-CCD: CSC NIKKAJI: J4.815A ATOM 28 1 N1y N 29.8961 -19.2045 2 C1y C 29.8961 -17.8311 3 C2y C 31.0805 -19.9163 4 C5x C 28.5228 -19.2045 5 C1y C 28.5228 -17.8311 6 S2x S 31.0805 -17.1446 7 C2y C 32.2836 -19.2170 8 C6a C 31.0679 -21.2895 9 O5x O 27.5528 -20.1682 10 N1b N 26.3872 -17.2578 11 C1x C 32.2836 -17.8311 12 C1b C 33.4680 -19.8975 13 O6a O 29.8773 -21.9574 14 O6a O 32.2522 -21.9763 15 C5a C 25.2031 -16.5775 16 O7a O 34.6586 -19.2107 17 C1b C 24.0187 -17.2578 18 O5a O 25.2031 -15.2042 19 C7a C 35.8429 -19.8975 20 C1b C 22.8281 -16.5775 21 C1a C 37.0273 -19.2107 22 O6a O 35.8493 -21.2643 23 C1b C 21.6438 -17.2578 24 C1c C 20.4594 -16.5775 25 C6a C 19.2688 -17.2578 26 N1a N 20.4594 -15.2042 27 O6a O 18.0845 -16.5713 28 O6a O 19.2751 -18.6313 BOND 29 1 1 2 1 2 1 3 1 3 1 4 1 4 2 5 1 5 2 6 1 6 3 7 2 7 3 8 1 8 4 9 2 9 5 10 1 #Up 10 6 11 1 11 7 12 1 12 8 13 1 13 8 14 2 14 10 15 1 15 12 16 1 16 15 17 1 17 15 18 2 18 16 19 1 19 17 20 1 20 19 21 1 21 19 22 2 22 20 23 1 23 23 24 1 24 24 25 1 25 24 26 1 #Down 26 25 27 1 27 25 28 2 28 4 5 1 29 7 11 1 /// ENTRY C00445 Compound NAME 5,10-Methenyltetrahydrofolate FORMULA C20H22N7O6 EXACT_MASS 456.1632 MOL_WEIGHT 456.43 REACTION R01218 R01220 R01655 R02300 R02301 R02302 R04326 PATHWAY map00670 One carbon pool by folate map00720 Other carbon fixation pathways map01100 Metabolic pathways map01120 Microbial metabolism in diverse environments map01200 Carbon metabolism map01240 Biosynthesis of cofactors map04981 Folate transport and metabolism MODULE M00140 C1-unit interconversion, prokaryotes M00141 C1-unit interconversion, eukaryotes M00377 Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) NETWORK nt06038 Folate metabolism ENZYME 1.5.1.5 1.5.1.15 2.1.2.2 2.1.2.10 3.5.4.9 4.3.1.4 6.3.3.2 DBLINKS PubChem: 3733 ChEBI: 15638 NIKKAJI: J1.213.619F ATOM 33 1 C8y C 12.0400 -18.9000 2 N4x N 12.0400 -20.3000 3 C8y C 13.2524 -21.0000 4 C8y C 14.4649 -20.3000 5 C8y C 14.4649 -18.9000 6 N5x N 13.2524 -18.2000 7 N2y N 15.6773 -21.0000 #+ 8 C1y C 16.8897 -20.3000 9 C1x C 16.8897 -18.9000 10 N1x N 15.6773 -18.2000 11 C2x C 15.9684 -22.3694 12 N1y N 17.3607 -22.5158 13 C1x C 17.9302 -21.2368 14 N1a N 10.8276 -18.2000 15 O5x O 13.2524 -22.3998 16 C8y C 18.0711 -23.7460 17 C8x C 17.3753 -24.9511 18 C8x C 18.0753 -26.1636 19 C8y C 19.4753 -26.1635 20 C8x C 20.1711 -24.9584 21 C8x C 19.4711 -23.7459 22 C5a C 20.1786 -27.3815 23 N1b N 21.5600 -27.3812 24 O5a O 19.4792 -28.5933 25 C1c C 22.2554 -28.5851 26 C1b C 23.6598 -28.5849 27 C6a C 21.5675 -29.7767 28 O6a O 20.1603 -29.7770 29 O6a O 22.2543 -30.9657 30 C1b C 24.8724 -29.2600 31 C6a C 26.0849 -28.5600 32 O6a O 27.2973 -29.2600 33 O6a O 26.0849 -27.1602 BOND 36 1 1 2 1 2 2 3 1 3 3 4 1 4 4 5 2 5 5 6 1 6 1 6 2 7 4 7 1 8 7 8 1 9 8 9 1 10 9 10 1 11 5 10 1 12 7 11 2 13 11 12 1 14 12 13 1 15 8 13 1 16 1 14 1 17 3 15 2 18 12 16 1 19 16 17 2 20 17 18 1 21 18 19 2 22 19 20 1 23 20 21 2 24 16 21 1 25 19 22 1 26 22 23 1 27 22 24 2 28 23 25 1 29 25 26 1 #Up 30 25 27 1 31 27 28 2 32 27 29 1 33 26 30 1 34 30 31 1 35 31 32 1 36 31 33 2 /// ENTRY C00446 Compound NAME alpha-D-Galactose 1-phosphate; alpha-D-Galactopyranose 1-phosphate FORMULA C6H13O9P EXACT_MASS 260.0297 MOL_WEIGHT 260.14 REACTION R00502 R00955 R01092 R02329 R05326 R06057 R09632 R10622 PATHWAY map00052 Galactose metabolism map00520 Amino sugar and nucleotide sugar metabolism map01100 Metabolic pathways map01250 Biosynthesis of nucleotide sugars MODULE M00554 UDP-Gal biosynthesis, Gal => UDP-Gal M00632 Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P ENZYME 2.4.1.211 2.4.1.247 2.7.1.6 2.7.7.10 2.7.7.12 2.7.7.32 2.7.7.64 3.1.3.94 DBLINKS CAS: 2255-14-3 PubChem: 3734 ChEBI: 17973 KNApSAcK: C00007391 PDB-CCD: GL1 NIKKAJI: J92.787B ATOM 16 1 C1y C 22.5082 -15.4748 2 O2x O 21.2855 -14.7696 3 C1y C 22.5082 -16.8788 4 O2b O 23.7309 -14.7696 5 C1y C 20.0626 -15.4748 6 C1y C 21.2855 -17.5904 7 O1a O 23.7309 -17.5904 8 P1b P 25.1348 -14.7696 9 C1y C 20.0626 -16.8788 10 C1b C 18.8594 -14.7696 11 O1a O 21.2855 -18.9941 12 O1c O 26.5451 -14.7696 13 O1c O 25.1348 -13.2257 14 O1c O 25.1348 -16.1799 15 O1a O 18.8594 -17.5904 16 O1a O 17.7985 -15.5007 BOND 16 1 1 2 1 2 1 3 1 3 1 4 1 #Down 4 2 5 1 5 3 6 1 6 3 7 1 #Down 7 4 8 1 8 5 9 1 9 5 10 1 #Up 10 6 11 1 #Up 11 8 12 1 12 8 13 1 13 8 14 2 14 9 15 1 #Up 15 10 16 1 16 6 9 1 /// ENTRY C00099 Compound NAME beta-Alanine; 3-Aminopropionic acid; 3-Aminopropanoate FORMULA C3H7NO2 EXACT_MASS 89.0477 MOL_WEIGHT 89.09 REMARK Same as: D07561 REACTION R00489 R00904 R00905 R00906 R00907 R00908 R00909 R00910 R00911 R00912 R00913 R00914 R00915 R00916 R00917 R01164 R01166 R02473 R02474 R02741 R03286 R03288 R03935 R09379 R09648 R10821 PATHWAY map00240 Pyrimidine metabolism map00410 beta-Alanine metabolism map00640 Propanoate metabolism map00770 Pantothenate and CoA biosynthesis map01100 Metabolic pathways map01110 Biosynthesis of secondary metabolites map01240 Biosynthesis of cofactors map04080 Neuroactive ligand-receptor interaction map04974 Protein digestion and absorption MODULE M00046 Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate M00119 Pantothenate biosynthesis, valine/L-aspartate => pantothenate M00913 Pantothenate biosynthesis, 2-oxoisovalerate/spermine => pantothenate ENZYME 1.2.1.3 1.2.1.5 1.2.1.19 1.5.1.26 2.6.1.18 2.6.1.19 2.6.1.55 2.6.1.120 2.8.3.- 3.4.13.4 3.4.13.5 3.4.13.18 3.4.13.20 3.5.1.6 3.5.1.21 3.5.1.22 3.5.1.100 3.5.3.17 4.1.1.11 4.1.1.15 6.3.2.1 6.3.2.11 6.3.2.23 6.3.2.36 6.3.2.44 BRITE Compounds with biological roles [BR:br08001] Peptides Amino acids Other amino acids C00099 beta-Alanine Amines Biogenic amines C00099 beta-Alanine DBLINKS CAS: 107-95-9 PubChem: 3399 ChEBI: 16958 KNApSAcK: C00001333 PDB-CCD: BAL NIKKAJI: J4.070C ATOM 6 1 C1b C 25.6778 -16.8919 2 C6a C 24.4732 -16.1936 3 C1b C 26.8940 -16.1936 4 O6a O 23.2571 -16.8978 5 O6a O 24.4732 -14.7912 6 N1a N 28.1045 -16.8919 BOND 5 1 1 2 1 2 1 3 1 3 2 4 1 4 2 5 2 5 3 6 1 ///